OptimizeRx Corp reports results for the quarter ended June 30 - Earnings Summary

• OptimizeRx Corp OPRX.OQ reported quarterly adjusted earnings of 24 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 2 cents. The mean expectation of seven analysts for the quarter was for earnings of 2 cents per share. Wall Street expected results to range from zero cents to 5 cents per share.

• Revenue rose 55.2% to $29.20 million from a year ago; analysts expected $22.26 million.

• OptimizeRx Corp's reported EPS for the quarter was 8 cents​.

• The company reported quarterly net income of $1.53 million.

• OptimizeRx Corp shares had fallen by 7.6% this quarter and gained 156.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 180% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the online services peer group is also "buy"

• Wall Street's median 12-month price target for OptimizeRx Corp is $16.00, about 19.8% above its last closing price of $12.84

This summary was machine generated from LSEG data August 8 at 03:17 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)